Newsroom | 38352 results

TORONTO--(BUSINESS WIRE)--Celltrion, Inc, une société biopharmaceutique internationale réputée, a annoncé que Remdantry™ sera disponible au Canada à partir du 1er avril 2025. Remdantry™, précédemment connu sous le nom d'Inflectra®, est le nouveau nom de marque de son premier anticorps monoclonal biosimilaire de Remicade (infliximab) au Canada. Celltrion a reçu l'avis de conformité (AC) de Santé Canada pour Remdantry™ le 7 mars 2025. Remdantry™ est homologué par le même numéro d'identification d...

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the full year ended December 31, 2024. Full Year 2024 Financial Results Net Loss from Continuing Operations Net loss from continuing operations was $(2.3) million, or $(0.20) per basic and diluted common share, a decrease of $5.4 million, compared to net loss from continuing operations of $(7.7) m...

NASHVILLE, Tenn.--(BUSINESS WIRE)--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, announced results for the fourth quarter and year ended December 31, 2024. The Company also posted its fourth quarter Letter to Stockholders and corporate presentation to the “Investors” section of its website, harrow.com. The Company encourages all Harrow stockholders to review these documents, which provide additional details concerning the historical quarterly period and future...

LOS ANGELES--(BUSINESS WIRE)--Sleep Awareness Month: Dr. Chavez Discusses How Sex and Intimacy Enhance Sleep Quality...

SAN DIEGO--(BUSINESS WIRE)--Physicians and affiliated researchers from Ivy Fertility, a globally-recognized network of fertility centers, shared cutting-edge research at the 73rd Annual Meeting of the Pacific Coast Reproductive Society (PCRS) in Indian Wells, California last week. “Ivy Fertility is proud to provide the world’s most compassionate fertility care, and that commitment is supported by our investment in industry-leading science,” said Ivy Fertility CEO Lisa Van Dolah. “By continually...

NASHVILLE, Tenn.--(BUSINESS WIRE)--Embold Health uses conversational AI to guide members to the right provider, lowering costs and improving health outcomes....

BIRMINGHAM, Ala.--(BUSINESS WIRE)--NaphCare, Inc., a leading correctional healthcare company, has developed the MyCare Patient Portal to improve access to care and provide patients 24/7 visibility into their personal health information. Delivered through digital tablets in correctional facilities, MyCare connects patients directly with healthcare staff and enables access to personal medical records, including test results, medication details, upcoming appointments, and patient education resourc...

BOULDER, Colo.--(BUSINESS WIRE)--Havah Therapeutics, a clinical stage biopharmaceutical company developing innovative therapies for prevention and treatment of breast cancers, announces the filing of a new provisional patent application directed to the use of HAV-088 for treating Ductal Carcinoma In-Situ. Backed by human in vivo data demonstrating on-target effect, the patent application covers the potential application of HAV-088, a novel androgen receptor (AR) agonist, in treating hormone rec...

PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Tuesday, May 6, 2025. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review first quarter 2025 financial results and respond to questions from financial analysts during the call. Investors and the public may access the live webcast by visiting the Zoetis website at http://investor.zoetis.com/events-presentations...

FOSTER CITY, Calif.--(BUSINESS WIRE)--LIVMARLI Now Approved in Japan for ALGS and PFIC...